Skip to main content
Clinical Trials/NCT04464278
NCT04464278
Unknown
Not Applicable

Predictive Value of Variation in Body Composition on the Fate of Older Subjects During SSR Hospitalization (Suite Care and Rehabilitation)

Assistance Publique - Hôpitaux de Paris0 sites360 target enrollmentJuly 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Body Weight Changes
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
360
Primary Endpoint
The prognosis value of variation of weight on mortality
Last Updated
5 years ago

Overview

Brief Summary

The aim of this study is to correlate weight variation as well as body composition with mortality and unscheduled readmission of geriatric population

Detailed Description

Weight loss in obese adults confers health benefits, while weight loss in the elderly is associated with an increased risk of mortality. There are a large number of studies associating weight loss and mortality but the relationships between changes in body composition (ratio between fat mass and lean mass) and mortality are often contradictory and poorly understood in elderly subject. The aim at this study is to request at this question.

Registry
clinicaltrials.gov
Start Date
July 2020
End Date
October 2023
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient ≥70 years old
  • Hospitalized in SSR for less than 7 days
  • No patient opposition

Exclusion Criteria

  • patient with a pacemaker
  • lake of nutritional assessment on admission
  • lake of assessment of autonomy at admission
  • Patient under guardianship or curatorship
  • Patient participating in another clinical research
  • Patient for whom a short stay (\<21 days) is planned in SSR

Outcomes

Primary Outcomes

The prognosis value of variation of weight on mortality

Time Frame: 3 months

Determination of variation of weight between D0 and D21 after inclusion

Mortality rate

Time Frame: 3 months

Monitoring of survival at 3 months after inclusion

Secondary Outcomes

  • Lean mass pronostic value(3 months after the inclusion)
  • In fat mass pronostic value(3 months after the inclusion)
  • fat / lean mass ratio(3 months after the inclusion)
  • The pprognosis value of variation of weight on unscheduled readmission in SSR(Between D0 and D21)
  • Unscheduled readmission in SSR(during 15 days after the end of hospitalization)

Similar Trials